EUVIMEDSkopri EUVIMED
Übersichtsarbeit

Prostaglandin E 2 – EP4 Signaling at the Gut–Immune–Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance

Nila Ganamurali iD, Sarvesh Sabarathinam iD

Comprehensive Physiology · 2026

DOI: 10.1002/cph4.70099 ↗

At a glance

Übersichtsarbeit in Comprehensive Physiology, 2026. Written by Nila Ganamurali and 1 co-authors. Institution: Pharmaco-Netinformatics Research Lab, Department of Psychiatry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sc…. Major MEDLINE topics: Insulin Resistance, Dinoprostone, Obesity, Receptors, Prostaglandin E, EP4 Subtype. Cited 4 times so far (Crossref); 33 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Despite advances in dietary and pharmacologic therapies, obesity rates continue to escalate globally. Emerging evidence implicates the gut–immune interface as a key determinant of metabolic dysfunction. This review highlights the prostaglandin E 2 (PGE 2 ) EP4 signaling axis as a pivotal mediator linking gut dysbiosis to systemic insulin resistance. In obesity, elevated COX‐2‐derived PGE 2 reprograms the gut microbiota, depleting short‐chain fatty acid (SCFA)‐producing taxa and reducing regulatory T cell (Treg) homeostasis. The ensuing loss of intestinal integrity promotes metabolic endotoxemia and chronic low‐grade inflammation, culminating in insulin resistance. Targeting the PGE 2 –EP4 microbiota Treg network through EP4 antagonists or microbiome restoration offers a promising therapeutic strategy to restore metabolic balance and prevent obesity associated complications.

Subjects

MeSH terms (MEDLINE)

Insulin ResistanceDinoprostoneObesityReceptors, Prostaglandin E, EP4 SubtypeHumansAnimalsSignal TransductionGastrointestinal Microbiome

Author keywords

EP4 receptorgood health and well‐beinggut microbiotainnovationinsulin resistanceprostaglandin E2 (PGE2)short chain fatty acids (SCFAs)

Substances

DinoprostoneReceptors, Prostaglandin E, EP4 Subtype

Authors and institutions

  • Pharmaco-Netinformatics Research Lab, Department of Psychiatry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.

ORCID profiles: Nila Ganamurali, Sarvesh Sabarathinam

Cite

APA

Ganamurali, N., & Sabarathinam, S. (2026). Prostaglandin E 2 – EP4 Signaling at the Gut–Immune–Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance. Comprehensive Physiology. https://doi.org/10.1002/cph4.70099

Vancouver

Ganamurali N, Sabarathinam S. Prostaglandin E 2 – EP4 Signaling at the Gut–Immune–Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance. Comprehensive Physiology. 2026. doi:10.1002/cph4.70099

BibTeX
@article{Ganamurali2026,
  author = {Ganamurali, Nila and Sabarathinam, Sarvesh},
  title = {Prostaglandin E 2 – EP4 Signaling at the Gut–Immune–Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance},
  journal = {Comprehensive Physiology},
  year = {2026},
  doi = {10.1002/cph4.70099}
}
Start for free →